Clinical Trial Update: Pevonedistat and Decitabine in Treating Patients With High Risk Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

This update reports the completion of a Phase 1 study evaluating pevonedistat in combination with decitabine for high-risk acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)
• Pevonedistat (pevonedistat)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED